Dr. Anusheel Munshi

Dr. Anusheel Munshi is a Principal Director and Head of the Radiation Oncology Department at BLK-Max Super Speciality Hospital in New Delhi, India. A Gold Medallist with over 28 years of clinical experience, Dr. Munshi has established himself as one of India's most accomplished radiation oncologists, bringing extensive expertise across multiple cancer sites and advanced treatment modalities to his practice.

Throughout his career, Dr. Munshi has developed deep clinical proficiency in precision radiation therapy techniques including 3D conformal radiotherapy, intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT). He is particularly skilled in CyberKnife radiosurgery and brachytherapy, treating complex cases across head and neck, lung, breast, gynaecologic, gastrointestinal, and paediatric cancers. His training includes prestigious international fellowships—a Novartis AROI overseas fellowship at The Royal Marsden Hospital in the United Kingdom and a UICC ICRETT fellowship at Long Beach Memorial Hospital in California—ensuring his practice aligns with global oncology standards.

Dr. Munshi is experienced in managing international patients seeking world-class cancer treatment. His practice welcomes patients from the Gulf region, East Africa, and the broader SAARC community, with fluency in English and Hindi ensuring clear communication throughout their care journey. He combines evidence-based precision medicine with compassionate, patient-centric care, addressing not only the clinical dimensions of cancer treatment but also the emotional and practical needs of families navigating complex diagnoses.

BLK-Max Super Speciality Hospital, where Dr. Munshi leads the Radiation Oncology department, is one of New Delhi's premier cancer centres, recognised for its advanced treatment infrastructure, multidisciplinary tumour boards, and strong international patient services. The hospital's state-of-the-art radiotherapy equipment, rigorous quality protocols, and integrated care model make it a trusted destination for patients seeking precision oncology. International patients benefit from seamless admission processes, dedicated medical tourism support, and comprehensive pre- and post-treatment follow-up, whether on-site or remotely.